Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB and IIIA Non-small Cell Lung Cancer

Conditions:   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-small Cell Lung Cancer Interventions:   Device: ViewRay MR-Linear Accelerator;   Radiation: Radiation therapy;   Drug: Paclitaxel;   Drug: Carboplatin AUC;   Biological: Durvalumab Sponsor:   Washington University School of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials